All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

Prediction of critically ill patients in a systemic manner based on clear, objective data is an essential part of care in an Intensive Care Unit (ICU). The development of severity scoring systems has been transformed to predict outcomes in a more objective and reliable way and has sequentially influenced management decisions, including do-not-resuscitate status and the withdrawal of life support \[[@pone.0211075.ref001]\]. Severity scoring systems have continued to be developed and various scoring systems have been used for the critical ill patient. Severity scoring systems should have validity, calibration, and discrimination to predict the severity of disease and mortality, as well as repeatability and reliability in different populations and diseases \[[@pone.0211075.ref002], [@pone.0211075.ref003]\]. There are generally two kinds of prediction models due to the different characteristics of individual diseases. One is used for the general intensive care patients and is focused on the acute physiological status and associated comorbidities assessed by the Acute Physiologic and Chronic Health Evaluation (APACHE) II \[[@pone.0211075.ref004]\], Simplified Acute Physiologic Score (SAPS) II \[[@pone.0211075.ref005]\], Logistic Organ Dysfunction Score (LODS) \[[@pone.0211075.ref006]\], and Sequential Organ Failure Assessment (SOFA) \[[@pone.0211075.ref007]\]. The other is specific to each individual disease and consists of the disease-related features. Among burn patients, the abbreviated burn severity index (ABSI) \[[@pone.0211075.ref008]\], FLAMES (Fatality by Longevity, APACHE II score, Measured Extent of burn, and Sex) \[[@pone.0211075.ref009]\], the revised Baux index (rBaux) \[[@pone.0211075.ref010]\], the models which were developed by Ryan et al \[[@pone.0211075.ref011]\], and the Belgian outcome in burn injury (BOBI)\[[@pone.0211075.ref012]\] group are known and used widely. These burn-specific prediction models, with the exception of FLAMES, consist of patient-related factors; no laboratory variables are included and even in FLAMES there is not burn specific laboratory factors. Therefore, these models are only able to determine some of the risk factors for mortality rather than a continuous range of risk factors \[[@pone.0211075.ref009]\]. It is necessary to develop a prediction model that includes a wider range of treatment-related biological variables as well as patient-related variables to accurately reflect the rapid progress in burn treatment. Additionally, the existing scoring systems for the general critically ill patients do not accurately predict the severity and the risk of mortality in the burn patients because they were developed from the general ICU, and did not specifically take into consideration burn populations \[[@pone.0211075.ref013]\].

The purpose of this study was to develop a new prediction model for mortality among burn patients that included specific laboratory tests to better reflect the risk of mortality and severity of disease as survival rates have increased due to the development of burn treatment in recent years. Additionally, we aimed to evaluate whether the newly developed prediction model could predict the risk of mortality more accurately than existing scoring systems.

Materials and methods {#sec006}
=====================

Patients {#sec007}
--------

This study included 2009 patients aged more than 18 years who were admitted within 24 hours after a burn in the burn intensive care unit (BICU) of Hangang Sacred Heart Hospital, Hallym University Medical Center from January 2007 to September 2017. The criteria for admission to BICU were as follows; 1) partial thickness burn of more than 20% of total body surface area (TBSA) for adults and partial thickness burn of more than 10% of TBSA if the patient was over 65 years of age, 2) inhalation injury, 3) electrical burn, 4) pre-existing medical disorder that could incur complications, or affect mortality, and 5) with concomitant trauma, which could elevate the risk of the morbidity or mortality. We divided the patients into two groups to develop and validate the new Hangang model; the patients who were admitted from January 2007 to December 2013 were included in the derivation group and the patients who were admitted form January 2014 to September 2017 were included in the validation group. This study was approved by the Institutional Review Board of Hangang Sacred Heart Hospital. Informed consent was waived due to the retrospective nature of the study.

Variables and prediction models {#sec008}
-------------------------------

All medical records of patients were retrieved from the clinical data warehouse which stored all electronic medical records anonymously in Hallym University Medical Center. The following demographic variables were collected; age, sex, type of burn, percentage of TBSA (% TBSA) burned, presence of inhalation, pre-existing medical history. There were no missing data; all subjects had complete data. The outcome of the prediction models was the 60-day mortality. We evaluated 10 prediction models. Five models such as ABSI \[[@pone.0211075.ref008]\], Ryan \[[@pone.0211075.ref011]\], FLAMES\[[@pone.0211075.ref009]\], BOBI \[[@pone.0211075.ref012]\] and the revised Baux \[[@pone.0211075.ref010]\] which are specific for burn patients and the most well-known \[[@pone.0211075.ref002]\], were calculated from electronic medical records. The ABSI scores consisted of five variables; age (1--5 points), % TBSA burned (1--10 points), female gender (1 point), the presence of inhalation injury (1 point), and the presence of full-thickness burn (1 point). The Ryan score was the sum of the presence of three risk factors (greater than 60 years of age, greater than 40% TBSA, and the presence of inhalation injuries). The FLAMES score was calculated using age, the percentage of partial and full thickness burns, gender, and the APACHE II score on day 1. The BOBI score was calculated using age (0--3 points), % TBSA burned (0--4 points), and the presence of inhalation injury (3 points). The revised Baux score was calculated using age + % TBSA burned + 17 (presence of inhalation injury). Inhalation injuries were diagnosed based on the patients' history (burned in a closed space, unconscious at the scene, prolonged extrication), physical findings such as singed facial hair, carbonaceous deposits in the nose or mouth, or facial burns, and other diagnostic modalities such as bronchoscopy, carbon monoxide levels, and serial chest x-rays. The presence of medical comorbidities was identified based on the presence of one or more of the following; cardiac disease, liver or kidney disease, and diabetes mellitus. APACHE II\[[@pone.0211075.ref004]\], SPAS II\[[@pone.0211075.ref005]\], LODS\[[@pone.0211075.ref006]\], SOFA\[[@pone.0211075.ref007]\] which are models generally used for the critical ill patients, were also calculated using the electronic medical records. APACHE II and SAPS II, LODS score, and SOFA consisted of 12, 11, and six physiologic variables \[[@pone.0211075.ref003]\]. All laboratory variables were used in these prediction models; the models retrieved the worst value of laboratory variables during first 24 hours after admission.

Burn management {#sec009}
---------------

All patients who were admitted to BICU received initial fluid resuscitation using the modified Parkland formula (4 mL × kg × % TBSA burned); the fluid volume was adjusted as needed to maintain a minimum urine output of 0.5 mL/kg/hour. Enteral feeding was the first choice and initiated within 48 hours if there was no ileus; parenteral nutrition was supplemented to meet the target caloric requirements, which were measured using the European society of parenteral and enteral nutrition (ESPEN) guidelines for intensive care \[[@pone.0211075.ref014]\]. Burn wound dressing was conducted daily using hydrofoam and topical antimicrobials. Early excision and grafting with auto-/allograft was performed within 5 days after admission.

Statistical analysis {#sec010}
--------------------

Continuous variables distributed normally and non-normally were presented as means ± standard deviation (SD) and as medians (25^th^ interquartile range \[IQR\] - 75^th^ IQR), respectively. The paired t-test or Wilcoxon signed rank test, depending on the normality of the data, was used to determine differences between the two groups. Categorical variables are presented as proportions and differences between them were analyzed using Chi-square tests. Two side p-values \<0.05 were considered statistically significant. All statistical analyses were conducted using the computing statistical R-project program version 3.5.1.

Development of the new prediction model (Hangang) {#sec011}
-------------------------------------------------

The following 30 variables were obtained, including eight patients' variables (six demographic values, participants medical histories, and the Glasgow coma scale) and 22 physiologic values ([Table 1](#pone.0211075.t001){ref-type="table"}). To detect multicollinearity for the all variables in this model, we used variance inflation factors. Shrinkage methods (the least absolute shrinkage and selection operator \[LASSO\]) with 10-folds cross-validation were performed using the computing statistical R-project program with the 'glmnet' package to determine the least number of variables for the development of the model and to limit overfitting of the model. Then, ten variables including age, % TBSA burned, inhalation injuries, serum lactate, pH, prothrombin time (PT), serum bilirubin, serum myoglobin, serum creatinine, and lactate dehydrogenase (LD) were included finally in the Hangang model.

10.1371/journal.pone.0211075.t001

###### The logistic regression coefficients and the assigned points for categorized variables included in the new prediction model.

![](pone.0211075.t001){#pone.0211075.t001g}

  -------------------------------------------------------------------------------
                            Coefficient   p-value    Weight    Weight\   Points
                                                               Scalded   
  ------------------------- ------------- ---------- --------- --------- --------
  Intercept                 -6.674        \< 0.001   -48.146   0.000     0

  Age ≤ 50                  0.000                    0.000     10.024    10

  Age 51--65                1.389         \< 0.001   10.017    20.041    20

  Age \> 65                 3.181         \< 0.001   22.943    32.968    33

  \% TBSA burned ≤ 20       0.000                    0.000     10.024    10

  \% TBSA burned 21--40     1.060         0.002      7.646     17.670    18

  \% TBSA burned 41--65     2.136         \< 0.001   15.407    25.431    25

  \% TBSA burned 66--75     3.659         \< 0.001   26.392    36.416    36

  \% TBSA burned \> 75      5.811         \< 0.001   41.919    51.944    52

  No inhalation             0.000                    0.000     10.024    10

  Inhalation                0.422         0.091      3.045     13.070    13

  Lactate ≤ 2.0             0.000                    0.000     10.024    10

  Lactate 2.1--4.0          0.659         0.057      4.751     14.775    15

  Lactate \> 4.0            1.322         \<0.001    9.534     19.559    20

  pH ≤ 7.25                 0.000                    0.000     10.024    10

  pH 7.26--7.35             -0.712        0.041      -5.135    4.889     5

  pH \> 7.35                -1.216        0.001      -8.772    1.253     1

  PT ≤ 11                   0.000                    0.000     10.024    10

  PT 12--14                 0.762         0.005      5.500     15.524    16

  PT \> 14                  1.618         \<0.001    11.675    21.699    22

  Bilirubin ≤ 1.2           0.000                    0.000     10.024    10

  Bilirubin 1.3--2.4        0.400         0.114      2.885     12.909    13

  Bilirubin \> 2.4          0.640         0.123      4.619     14.643    15

  Serum myoglobin ≤ 65      0.000                    0.000     10.024    10

  Serum myoglobin 66--145   0.359         0.352      2.592     12.617    13

  Serum myoglobin \> 145    0.912         0.005      6.575     16.600    17

  Creatinine ≤ 1.2          0.000                    0.000     10.024    10

  Creatinine \> 1.2         0.591         0.053      4.260     14.284    14

  LD ≤ 300                  0.000                    0.000     10.024    10

  LD 301--750               0.633         0.128      4.568     14.592    15

  LD \> 750                 1.405         0.003      10.138    20.162    20
  -------------------------------------------------------------------------------

%TBSA burn, the percent of total body surface area burned; n, number; FB, flame burn; SB, scald burn; EB, electrical burn; ChB, chemical burn; PT, prothrombin time; LD, lactate dehydrogenase

The continuous features were divided into groups which were mapped to a target variable (mortality) by supervised discretization using algorithms such as Recursive Partitioning, which can identify optimal cut points and evaluate the relationship with the outcome using the Weight of Evidence and Information Values \[[@pone.0211075.ref015]\]. The optimal cut points were adjusted to ensure the model was simple and easy to interpret. Then the variables were categorized by the adjusted cut points. The points were assigned to the categorized variable using the coefficients calculated using the computing statistical R-project program with the 'smbinning' package ([Table 1](#pone.0211075.t001){ref-type="table"}). A nomogram of the Hangang model shows the scores of each variable ([Table 2](#pone.0211075.t002){ref-type="table"}). The minimum and maximum scores of the Hangang model ranged from 91 to 216 and the probability (%) of mortality according to scores ([Table 3](#pone.0211075.t003){ref-type="table"}).

10.1371/journal.pone.0211075.t002

###### The score for each variable and probability of mortality in the new prediction model (Hangang).
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  Score               1        5        10       13     14      15      16      17      18    20      22       25    33     36    52
  ------------------- -------- -------- -------- ------ ------- ------- ------- ------- ----- ------- -------- ----- ------ ----- ------
  Age(years)                            ≤ 50                                                  ≤65                    \>65         
  %TBSA burned                          ≤ 20                                            ≤40                    ≤65          ≤75   \>75
  Inhalation injury                     No       Yes                                                                              
  lactate(mmol/L)                       ≤ 2.0                   ≤4.0                          \>4.    0                           
  pH                  \>7.35   ≤ 7.35   ≤ 7.25                                                                                    
  PT(sec)                               ≤11.0                           ≤14.0                         \>14.0                      
  bilirubin(mg/dL)                      ≤1.2     ≤2.4           \>2.4                                                             
  Myoglobin(ng/mL)                      ≤65      ≤145                           \>145                                             
  Creatinine(mg/dL)                     ≤1.2            \>1.2                                                                     
  LD(IU/L)                              ≤300                    ≤750                          \>750                               

%TBSA burned, the percentage of total body surface area burned; PT, prothrombin time; LD, lactate dehydrogenase

10.1371/journal.pone.0211075.t003

###### Predicted mortality according to scores.
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  Total Scores        91   128   133   141   149   157   165   216
  ------------------- ---- ----- ----- ----- ----- ----- ----- ------
  Mortality risk(%)   0%   5%    10%   25%   50%   75%   90%   100%

Model performance {#sec012}
-----------------

The discrimination was analyzed by the area under the curve (AUC) of the receiver operating characteristic curve (ROC); as the AUC approaches one, the discriminating power increased \[[@pone.0211075.ref016]\]. The Brier score was calculated; a Brier score of 0 indicates total accuracy \[[@pone.0211075.ref017]\]. The integrated discrimination improvement (IDI) and the net reclassification improvement (NRI) were also calculated using category options between the Hangang and other existing models using the computing statistical R-project program with the 'PredictABEL' package. The calibration was analyzed using the Hosmer-Lemeshow goodness-of-fit test (HL test), which assesses how well the mortality pattern in the data under analysis is described; non-significant p-values indicated that the fit of the model was good \[[@pone.0211075.ref018]\]. Clinical usefulness, or the ability to make better decisions with a model than without, was not assessed by discrimination and calibration \[[@pone.0211075.ref019]\]. Therefore, we also performed a decision-curve analysis. The code and manual for the decision-curve analysis is publicly available ([www.decisioncurveanalysis.org](http://www.decisioncurveanalysis.org/)).

Results {#sec013}
=======

Comparison of baseline characteristic between the derivation group and validation group {#sec014}
---------------------------------------------------------------------------------------

In total, 2009 patients were included in this study; they were then divided into the derivation (n = 1406) and validation (n = 603) groups. The overall median age was 47.0 (38.0--56.0) years and participants were older in the validation group than in the derivation group (49.0 years vs 46.0 years, p = 0.003). The overall % TBSA burned was 30.0%; there was no significant difference between the two groups based on % TBSA burned (p = 0.127). Inhalation injuries were significantly more frequent in the derivation group (57.3% vs 51.1%, p = 0.011) and the patients in the validation group had more medical comorbidities (46.8% vs 21.0%, p\<0.001). Overall mortality was 21.7% and there was no significant difference between the two groups. The validation group had significant differences in patient characteristics with the exception of sex (p = 0.409) and the type of burns (p = 0.099). The scores of the prediction models such as ABSI, rBaux, Ryan BOBI, FLAMES for burn patient did not significantly differ between the two groups. Only the SOFA scores for the prediction models for ICU patients did not significantly differ ([Table 4](#pone.0211075.t004){ref-type="table"}). All physiologic variables are shown in the [Table 4](#pone.0211075.t004){ref-type="table"}.

10.1371/journal.pone.0211075.t004

###### Comparison of the baseline characteristics between the derivation and validation groups.
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  ------------------------------------------------------------------------------------------------------------
                              Total\                  Derivation\             Validation\            p-value
                              (n = 2009)              (n = 1406)              (n = 603)              
  --------------------------- ----------------------- ----------------------- ---------------------- ---------
  Patient characteristics                                                                            

  Age (years)                 47.0(38.0--56.0)        46.0(38.0--55.0)        49.0(38.0--58.0)       0.003

  Sex (male, %)               1656(82.4%)             1152(81.9%)             504(83.6%)             0.409

  Type(FB:SB:EB:ChB:CoB)      1493:161:276:30:49      1061:112:180:17:36      432:49:96:13:13        0.099

  %TBSA burned                30.0(17.0--50.0)        30.0(18.0--50.0)        29.0(16.0--46.0)       0.127

  Inhalation Injury           1114(55.5%)             806(57.3%)              308(51.1%)             0.011

  Medical History             577(28.7%)              295(21.0%)              282(46.8%)             \<0.001

  GCS                         15.0(15.0--15.0)        15.0(15.0--15.0)        15.0(11.0--15.0)       \<0.001

  Physiologic variables                                                                              

  MAP(mmHg)                   86.0(73.0--99.0)        86.0(73.3--99.0)        86.3(72.5--98.0)       0.777

  Heart rate(                 82.0(70.0--98.0)        83.0(70.0--99.0)        81.0(70.0--98.0)       0.458

  Respiratory rate            21.0(20.0--24.0)        22.0(20.0--24.0)        21.0(19.0--24.0)       0.002

  Temperature(°C)             37.0(36.5--37.6)        37.0(36.5--37.5)        37.0(36.5--37.6)       0.233

  PF ratio                    275.7(204.0--348.3)     269.8(202.0--336.7)     290.0(212.9--398.8)    \<0.001

  Sodium(mEq/L)               141.0(138.0--143.0)     141.0(139.0--144.0)     140.0(138.0--142.0)    \<0.001

  Potassium(mEq/L)            4.2(3.9--4.6)           4.2(3.9--4.7)           4.1(3.8--4.6)          0.020

  Urine output(ml/day)        1000.0(530.0--1665.0)   1000.0(530.0--1660.0)   970.0(500.0--1685.0)   0.699

  BUN(mg/dL)                  15.0(11.8--18.8)        15.2(12.0--19.0)        14.5(11.4--18.1)       0.003

  Creatinine(mg/dL)           0.8(0.7--1.0)           0.8(0.7--1.0)           0.8(0.7--1.0)          0.715

  pH                          7.4(7.3--7.4)           7.4(7.3--7.4)           7.4(7.3--7.4)          \<0.001

  Bicarbonate(mmol/L)         20.9(18.3--22.8)        21.1(18.6--22.7)        20.1(17.6--23.1)       0.096

  WBC(10^3^/uL)               15.3(11.2--20.9)        15.6(11.6--21.7)        14.6(10.4--19.3)       \<0.001

  Hct(%)                      47.6(43.2--53.3)        47.6(43.2--53.4)        47.7(43.4--53.1)       0.844

  Platelet(10^3^/uL)          222.0(172.0--279.0)     228.0(179.0--284.0)     209.0(163.0--265.5)    \<0.001

  Bilirubin(mg/dL)            0.8(0.6--1.2)           0.8(0.6--1.3)           0.8(0.5--1.1)          \<0.001

  PT(sec)                     11.8(11.0--12.9)        11.4(10.8--12.3)        12.7(11.8--13.6)       \<0.001

  Lactate(mmol/L)             2.9(1.8--4.9)           2.8(1.7--4.7)           3.3(2.2--5.4)          \<0.001

  CK(IU/L)                    300.0(158.0--1103.0)    315.5(164.0--1093.0)    278.0(148.5--1117.5)   0.147

  LD(IU/L)                    410.0(287.0--620.0)     440.5(307.0--656.0)     341.0(251.0--530.5)    \<0.001

  Serum myoglobin(ng/mL)      161.0(53.0--799.0)      176.5(60.0--911.0)      114.0(38.0--680.0)     \<0.001

  Urine myoglobin(+)          695(34.6%)              399(28.4%)              296(49.1%)             \<0.001

  Severity systems for burn                                                                          

  ABSI                        8.0(6.0--10.0)          8.0(6.0--10.0)          8.0(6.0--10.0)         0.071

  rBaux                       88.0(69.0--111.0)       88.0(69.0--112.0)       87.0(68.0--109.5)      0.434

  Ryan                        1.0(0.0--2.0)           1.0(0.0--2.0)           1.0(0.0--2.0)          0.068

  BOBI                        4.0(2.0--5.0)           4.0(2.0--5.0)           3.0(1.0--5.0)          0.235

  FLAMES                      -3.1(-4.8--0.6)         -3.2(-4.9--0.7)         -2.9(-4.8--0.4)        0.224

  Hangang                     126.0(114.0--143.0)     125.0(113.0--143.0)     127.0(116.0--145.0)    0.018

  Severity system in ICU                                                                             

  APACHE II                   9.0(6.0--14.0)          8.0(6.0--13.0)          10.0(6.0--17.0)        \<0.001

  SAPS2                       17.0(10.0--27.0)        16.0(9.0--25.0)         20.0(11.0--32.0)       \<0.001

  LODS                        2.0(0.0--5.0)           1.0(0.0--5.0)           3.0(0.0--5.0)          \<0.001

  SOFA                        2.0(2.0--4.0)           2.0(2.0--4.0)           3.0(2.0--5.0)          0.366

  Mortality                   435(21.7%)              305(21.7%)              130(21.6%)             0.994
  ------------------------------------------------------------------------------------------------------------

n, number; FB, Flame Burn; SB, Scald Burn; EB, Electrical Burn; ChB, Chemical Burn; CoB, Contact Burn; %TBSA burned, percentage of total body surface area burned; MAP, Mean Arterial Pressure; PF ratio, ratio of arterial O~2~ pressure to fraction of inspired oxygen; WBC, White Blood Cell; Hct, Hematocrit; PT, Prothrombin Time; CK, Creatine Kinase; LD, Lactate Dehydrogenase; GCS, Glasgow Coma Scale; ABSI, Abbreviate Burn Severity Index; rBaux, revised Baux index; BOBI, Belgian Outcome in Burn Injury; FLAMES, Fatality by Longevity, APACHE II score, Measured Extent of burn, and Sex; APACHE, Acute Physiology and Chronic Health Evaluation Score; SAPS, Simplified Acute Physiology Score; LODS, Logistic Organ Dysfunction Score; SOFA, Sequential Organ Failure Assessment

Validation of the existing models in the derivation cohort {#sec015}
----------------------------------------------------------

Prior to validation of the new model, we evaluated the performance measures of nine existing scoring systems to determine their predictive ability. The AUC was the highest (0.957) and the Brier score was the lowest (0.071) in the Hangang model when compared with other models. The NRI and IDI were 0.504 (p-values \<0.001) and 0.045 (p-values \<0.001) for Hangang when compared with FLAMES. Hangang (HL test, χ^2^ = 8.354, p = 0.400), FLAMES (HL test, χ^2^ = 4.973, p = 0.760), and the Ryan score (HL test, χ^2^ = 0.359, p = 0.549) had significantly better calibration among all the models tested for burn patients and SAPS II (HL test, χ^2^ = 8.958, p = 0.346) had significantly better calibration among the models tested for ICU patients ([Table 5](#pone.0211075.t005){ref-type="table"}).

10.1371/journal.pone.0211075.t005

###### Performance measures of existing prediction model in derivation group.
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  --------------------------------------------------------------------------------------------------------------------------------------------------
  Score       AUC\             p-value     NRI\              p-value     IDI\             p-value     Brier score   Hosmer-Lemeshow χ^2^   p-value
              (95% CI)                     (95%CI)                       (95% CI)                                                          
  ----------- ---------------- ----------- ----------------- ----------- ---------------- ----------- ------------- ---------------------- ---------
  Hangang     0.958\           Reference   Reference         Reference   Reference        Reference   0.063         5.271                  0.728
              (0.947--0.968)                                                                                                               

  For burns                                                                                                                                

  FLAMES      0.939\           0.001       0.036\            0.108       0.048\           \<0.001     0.071         7.434                  0.491
              (0.924--0.954)               (-0.008--0.081)               (0.024--0.072)                                                    

  rBaux       0.921\           \<0.001     0.071\            0.003       0.109\           \<0.001     0.081         18.092                 0.021
              (0.903--0.939)               (0.024--0.118)                (0.084--0.134)                                                    

  ABSI        0.906\           \<0.001     0.096\            \<0.001     0.135\           \<0.001     0.085         17.010                 0.017
              (0.886--0.926)               (0.046--0.146)                (0.108--0.162)                                                    

  BOBI        0.885\           \<0.001     0.156\            \<0.001     0.216\           \<0.001     0.097         71.937                 \<0.001
              (0.864--0.906)               (0.108--0.203)                (0.189--0.243)                                                    

  Ryan        0.844\           \<0.001     0.555\            \<0.001     0.314\           \<0.001     0.117         0.359                  0.549
              (0.824--0.865)               (0.498--0.612)                (0.282--0.347)                                                    

  In ICU                                                                                                                                   

  APACHE II   0.884\           \<0.001     0.246\            \<0.001     0.262\           \<0.001     0.109         24.704                 0.002
              (0.864--0.904)               (0.178--0.314)                (0.224--0.301)                                                    

  SAPS2       0.857\           \<0.001     0.275\            \<0.001     0.301\           \<0.001     0.114         8.958                  0.346
              (0.834--0.880)               (0.200--0.349)                (0.257--0.344)                                                    

  SOFA        0.834\           \<0.001     0.321\            \<0.001     0.321\           \<0.001     0.117         15.747                 0.003
              (0.806--0.861)               (0.254--0.389)                (0.280--0.362)                                                    

  LODS        0.786\           \<0.001     0.381\            \<0.001     0.412\           \<0.001     0.132         28.765                 \<0.001
              (0.756--0.815)               (0.309--0.453)                (0.370--0.454)                                                    
  --------------------------------------------------------------------------------------------------------------------------------------------------

AUC, Area Under the Curve; FLAMES, Fatality by Longevity, APACHE II score, Measured Extent of burn, and Sex; rBaux, revised Baux index; ABSI, Abbreviate Burn Severity Index, BOBI, Belgian Outcome in Burn Injury; ICU, Intensive Care Unit; APACHE, Acute Physiology and Chronic Health Evaluation Score; SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment; SOFA, Sequential Organ Failure Assessment; LODS, Logistic Organ Dysfunction Score

Validation of the new model (Hangang) in the validation cohort {#sec016}
--------------------------------------------------------------

Even though the demographic and physiologic characteristics of the validation group differed compared to the derivation group, the Hangang model showed improved prediction of the risk of mortality. Hangang had better calibration (HL test, χ^2^ = 8.785, p = 0.361) for predicting mortality; this was reinforced by the highest AUC (0.943) and the lowest Brier score (0.068). The NRI and IDI when compared with FLAMES were 0.124 (p = 0.003) and 0.079 (p-values \<0.001), respectively. Among the prediction models tested for ICU patients, SAPS II had the highest AUC (0.860), an accuracy of 0.786, the lowest Brier score (0.115), and a HL test χ^2^ of 6.489 (p = 0.593) ([Table 6](#pone.0211075.t006){ref-type="table"}). The calibration plots for all the existing models included in this study are shown in the Figs [1](#pone.0211075.g001){ref-type="fig"} and [2](#pone.0211075.g002){ref-type="fig"}. The decision-curve indicates that the Hangang model was the best for predicting the probability of mortality ([Fig 3](#pone.0211075.g003){ref-type="fig"}).

![Calibration plots for the Hangang and models specific for burn patients in the validation group.\
Hosmer-Lemeshow goodness of fit statistics are presented in [Table 6](#pone.0211075.t006){ref-type="table"}.](pone.0211075.g001){#pone.0211075.g001}

![Calibration plots for the Hangang and models for patients in the intensive care unit.\
Hosmer-Lemeshow goodness of fit statistics are presented in [Table 6](#pone.0211075.t006){ref-type="table"}.](pone.0211075.g002){#pone.0211075.g002}

![Decision curve analysis for the Hangang model compared with 1) models specific for burn patients, 2) models for patients in the intensive care unit.](pone.0211075.g003){#pone.0211075.g003}

10.1371/journal.pone.0211075.t006

###### Performance measures of new Hangang model comparing with existing prediction model in validation group.

![](pone.0211075.t006){#pone.0211075.t006g}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Score       AUC\             p-value[\*](#t006fn001){ref-type="table-fn"}   NRI\             p-value     IDI\             p-value     Brier score   Hosmer-Lemeshow χ^2^   p-value
              (95% CI)                                                        (95% CI)                     (95% CI)                                                          
  ----------- ---------------- ---------------------------------------------- ---------------- ----------- ---------------- ----------- ------------- ---------------------- ---------
  Hangang     0.943\           Reference                                      Reference        Reference   Reference        Reference   0.068         8.785                  0.361
              (0.921--0.966)                                                                                                                                                 

  For burns                                                                                                                                                                  

  FLAMES      0.927\           0.090                                          0.124\           0.003       0.079\           \<0.001     0.084         11.991                 0.152
              (0.904--0.951)                                                  (0.042--0.206)               (0.038--0.120)                                                    

  rBaux       0.914\           0.008                                          0.118\           0.005       0.122\           \<0.001     0.091         9.391                  0.310
              (0.889--0.940)                                                  (0.035--0.202)               (0.079--0.165)                                                    

  ABSI        0.893\           \<0.001                                        0.123\           0.011       0.160\           \<0.001     0.097         6.640                  0.355
              (0.864--0.923)                                                  (0.29--0.217)                (0.114--0.206)                                                    

  BOBI        0.887\           \<0.001                                        0.126\           0.007       0.185\           \<0.001     0.099         18.262                 0.006
              (0.856--0.917)                                                  (0.034--0.217)               (0.139--0.231)                                                    

  Ryan        0.841\           \<0.001                                        0.103\           0.028       0.287\           \<0.001     0.118         1.373                  0.241
              (0.809--0.874)                                                  (0.011--0.195)               (0.234--0.340)                                                    

  In ICU                                                                                                                                                                     

  APACHE II   0.859\           \<0.001                                        0.241\           \<0.001     0.273\           \<0.001     0.117         11.308                 0.185
              (0.825--0.894)                                                  (0.135--0.347)               (0.215--0.331)                                                    

  SAPS2       0.860\           \<0.001                                        0.253\           \<0.001     0.267\           \<0.001     0.115         6.489                  0.593
              (0.826--0.893)                                                  (0.147--0.360)               (0.204--0.330)                                                    

  SOFA        0.827\           \<0.001                                        0.317\           \<0.001     0.307\           \<0.001     0.122         3.230                  0.665
              (0.786--0.869)                                                  (0.208--0.426)               (0.244--0.370)                                                    

  LODS        0.823\           \<0.001                                        0.329\           \<0.001     0.335\           \<0.001     0.126         10.802                 0.055
              (0.784--0.862)                                                  (0.222--0.436)               (0.271--0.400)                                                    
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*, p-value compared with new Hangang model

AUC, Area Under the Curve; FLAMES, Fatality by Longevity, APACHE II score, Measured Extent of burn, and Sex; rBaux, revised Baux index; ABSI, Abbreviate Burn Severity Index, BOBI, Belgian Outcome in Burn Injury; ICU, Intensive Care Unit; APACHE, Acute Physiology and Chronic Health Evaluation Score; SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment; SOFA, Sequential Organ Failure Assessment; LODS, Logistic Organ Dysfunction Score

Discussions {#sec017}
===========

Despite the existence of several prediction models, there are not many realistic models to accurately predict the outcomes of burn patients \[[@pone.0211075.ref020]\]. Various prediction models suggest that there is no ideal model to predict outcomes accurately in every population \[[@pone.0211075.ref002]\]. The ideal prediction model generally is simple, reliable, and objective (observer independent) \[[@pone.0211075.ref013]\]. However, in most burn-specific prediction models, it might be difficult to accurately reflect the risk of mortality, which has been changed as a result of the advancement of burn treatment. This is due to the fact that these models consist of patient-related variables (such as age and % TBSA) and do not contain objective laboratory values \[[@pone.0211075.ref021]\]. The % TBSA burned was the most powerful predictor in this study, however, it is measured differently based on the experience of the treating physician; the estimation error can be up to 20% among inexperienced physicians \[[@pone.0211075.ref022]\]. Therefore, in hospitals that are not specialized in treating burn patients, such errors can affect the model and make it difficult to accurately predict mortality. To compensate for these errors, prediction models should include the addition of objective laboratory results.

We assessed the validation of prediction models by calibration and decimation. Additionally, we assessed the ability to make better decisions with a model than without by conducting a decision-curve analysis \[[@pone.0211075.ref023]\]. The Hangang model showed that the net benefit (NB) was higher than other prediction models for patients in ICU and higher, with the exception of extremes, than other models for burn patients. These findings suggest that the Hangang model assists in making better decisions for the prediction of mortality.

Our model ensured accuracy, reliability, and objectivity by adding seven variables (lactate, pH, creatinine, PT, bilirubin, LD, serum myoglobin) associated with treatment over three variables (age, % TBSA burned, inhalation injury) which are commonly applied to existing burn specific prediction models, with the exception of FLAMES. Our model showed superiority when compared to the other existing models.

Among the laboratory variables included in this model, serum myoglobin and LD were not used as predictors for mortality in other prediction models. Serum myoglobin is associated with the burn depth and severity of the burn; previous studies have shown that burn patients with high myoglobinemia have a high risk of mortality \[[@pone.0211075.ref024], [@pone.0211075.ref025]\]. LD is also associated with burn diseases and mortality in patients with major burns \[[@pone.0211075.ref025]--[@pone.0211075.ref027]\]. When compared to FLAMES, which includes other physiologic variables (a form of APACHE II) similar to our Hangang model, we inferred that the Hangang model would have better prediction ability because burn-specific serum myoglobin and LD were included and other non-significant variables were excluded. Prediction models for the general ICU such as APACHE II, SAPS II, SOFA, and LODS showed poor predictability in critical burn patients. Therefore, caution should be taken when applying general prediction models to burn patients because they do not take into account the profound physiological effects of the burn itself, although they may prove valid in a general critical ill patients.\[[@pone.0211075.ref020]\]

This study was subject to several limitations. First, we did not validate the Hangang prediction score externally at other hospitals, because our burn center is the only burn center run by the Hallym university and has been designated as "The Emergency Center for Burn Care" by the Ministry for Health, Welfare, and Family Affairs in South Korea. However, validation was performed in the cohort recently treated in our center. Second, our study group did not include pediatric burn patients due to their different physiologic characteristics. Further studies including pediatric burn patients are needed. Third, not all patients who were admitted to BICU were included in this study; only acute burn patients who were admitted within 24 hours after injury were included in order to exclude other confounding factors. Fourth, although we collected the worst laboratory value over 24 hours for laboratory variables to minimize other affecting factors, the seven variables included in our model might have been affected by the level of fluid resuscitation, thus affecting our model.

Despite these limitations, it is important to recognize that our model reflects outcomes as a result of care provided under the current standards. Although our Hangang prediction model was developed in a single center, this is the largest study, to our knowledge, to date to test a new model for the prediction of mortality among burn patients. In the future, it might require modification to assist with decision-making as new therapies are introduced. We advocate that physicians who do not have much experience treating burns should consult experienced doctors when using this prediction model.

Conclusions {#sec018}
===========

There are many severity scoring systems widely used in the ICU to predict outcomes and characterize the severity of the disease. All of these scoring systems have been developed for the mixed population in the ICU. Their accuracy among subgroups, such as burn patients, is questionable and therefore, burn-specific scoring systems are required for accurate prediction. This model reflects the burn specific risk factors such as serum myoglobin and LD as well as current risk factors for mortality; it is a highly discriminatory and well-calibrated model for the prediction of mortality in adult burn patients.

Supporting information {#sec019}
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